However, gene therapies are often unaffordable to those that need them most. At $2 million a dose, only the very wealthiest can be cured with a single treatment. Depending on payors, this may not be accessible even in high income countries
Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve your body’s ability to fight disease. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS.
On a large scale, germline gene therapy could result in the selection of characteristics to “improve” the genetics of a population. The widespread use of germline gene therapy may make society less accepting of people who are different or who have a particular disability or genetic condition
In the case of gene therapies, prices are also affected by lack of competition, with a limited number of companies developing gene therapies for rare diseases, and by the fact that often only a small number of patients can benefit from a specific treatment, a situation in which profits from a small number of doses need
